Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2009
11/05/2009CA2722938A1 New peptidomimetic compounds
11/05/2009CA2722668A1 Methods for treating inflammation
11/05/2009CA2722571A1 Pharmaceutical gallium compositions and methods
11/05/2009CA2722137A1 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009CA2720908A1 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules
11/05/2009CA2716936A1 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
11/04/2009EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009EP2112926A2 Use of estrogen receptor beta selective ligands for treating acute lung injuries
11/04/2009EP1784388B1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1372638B1 Cannabinoids for the treatment of breathing disorders during sleep
11/04/2009EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612225 Endothelin receptor antagonist, useful for treating various circulatory system diseases such as hypertension, ischemic disorders, cerebral circulatory disorders, renal disorders, circulatory insufficiency of various organs, asthma, stroke
11/03/2009US7612113 Hydroxy tetrahydro-naphthalenylurea derivatives
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612083 Urea substituted imidazoquinoline ethers
11/03/2009US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009US7612047 Degradation-resistant mononucleoside phosphate compounds
11/03/2009US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009US7611730 Containing racemate of tramadol in slow-release form and (+)enantiomer of tramadol in immediate-release form; analgesic efficacy results from interplay of enantiomers by mechanism which includes non-opioid and opiod components
11/03/2009US7611729 Dosage forms having prolonged active ingredient release
11/03/2009CA2447924C Olopatadine formulations for topical administration
11/03/2009CA2383220C Controlled release pellet formulation
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
10/2009
10/29/2009WO2009132226A1 Thiolated chitosan gel
10/29/2009WO2009131695A1 Oligomer-bis-chromonyl compound conjugates
10/29/2009WO2009131171A1 Novel five-membered ring compound
10/29/2009WO2009131170A1 Five-membered ring compound
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130615A2 Use of deuterium oxide as an elastase inhibitor
10/29/2009WO2009129726A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
10/29/2009WO2009046856A3 Use of serorphin as a therapeutic agent
10/29/2009WO2009046824A3 Use of apelin-12 as a therapeutic agent, eg for treating excessive angiogenesis
10/29/2009WO2009043505A3 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
10/29/2009WO2009043504A3 Use of apelin-36 and optionally beta-melanotropin as therapeutic agents, eg for treating aids or alzheimer
10/29/2009WO2009040089A3 Use of the peptides maippkknqdk (cow kappa casein 106-116) and/or ygfqna (serorphin) as therapeutic agents
10/29/2009WO2009039996A3 Use of bradykinin alone or in combination with melanotan ii as a therapeutic agent
10/29/2009WO2009039977A3 Use of alpha-casein (90-96) as a therapeutic agent in eg the treatment of hbv infection
10/29/2009WO2009033781A3 Use of k237 as therapeutic agent
10/29/2009WO2009033751A3 Use of leu-enkephalin as a therapeutic agent
10/29/2009WO2009033718A3 Use of anti -inflammatory peptide 1 as a therapeutic agent
10/29/2009WO2009009173A3 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
10/29/2009US20090270454 Sulfonamide containing compounds for treatment of inflammatory disorders
10/29/2009US20090270441 Macrolides
10/29/2009US20090270382 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270368 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270364 Substituted pyrimidine derivatives
10/29/2009US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009US20090270318 High-affinity antagonists of elr-cxc chemokines
10/29/2009US20090270310 Process for the preparation of a nutrient formulation
10/29/2009US20090269349 Antigenic polypeptides
10/29/2009US20090269302 Human antibodies that bind human il-12 and methods for producing
10/29/2009DE102008020387A1 Use of pharmaceutical formulation comprising matrix e.g. polysaccharides cellulose and dextran, with protein adsorptive properties, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722065A1 Use of deuterium oxide as an elastase inhibitor
10/29/2009CA2722041A1 Novel five-membered ring compound
10/29/2009CA2722007A1 Five-membered ring compound
10/29/2009CA2721985A1 Thiolated chitosan gel
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP2111864A2 Therapeutic methods and uses of sapogenins and their derivatives
10/28/2009EP2111861A1 Compositions of phosphodiesterase type IV inhibitors
10/28/2009EP2111855A1 Antibacterial compositions for the treatment of infections of the upper and lower airways
10/28/2009EP1865966B1 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
10/28/2009EP1633717B1 P2x7 receptor antagonists and their use
10/28/2009EP1408967B1 PHARMACEUTICAL COMPOSITIONS BASED ON Tiotropium, Ciclesonide AND a BETAMIMETIC AGENT FOR THE TREATMENT OF INFLAMMATORY AND/OR OBSTRUCTIVE RESPIRATORY TRACT DISEASES
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101568540A Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/28/2009CN101564518A Traditional Chinese medicine for curing children cough
10/28/2009CN101564517A Traditional Chinese medicine for treating children cough and asthma and preparation thereof
10/28/2009CN101564514A Method for analyzing children Fengreqing particle
10/28/2009CN101564505A Chinese medicament for treating pulmonary heart disease
10/28/2009CN101564492A Traditional Chinese medicine drink for treating sore throat
10/28/2009CN101564490A Traditional Chinese medicine for curing chronic rhinitis
10/28/2009CN101564475A Application of Kegan Liyan Oral Liquid in preparing Chinese medicaments for preventing and treating bird flu
10/28/2009CN101564471A Preparation method of buccal tablets for treating laryngeal disease
10/28/2009CN101564461A Method for preparing Chinese medicine used for clearing heat, moistening lung, relieving cough, resolving phlegm, disinhibiting urine and freeing strangury
10/28/2009CN101564460A Application of Chinese medicinal composition in preparing medicament for treating chronic obstructive pulmonary disease
10/28/2009CN101564459A Application of Chinese medicinal composition in preparing medicament for treating upper respiratory tract infection
10/28/2009CN101564458A Application of Chinese medicinal composition in preparing medicament for treating bronchitis
10/28/2009CN101564455A Traditional Chinese medicine composition for preventing chronic respiratory disease of fowl and preparation method thereof
10/28/2009CN101564454A Traditional Chinese medicine for curing chicken infective bronchitis
10/28/2009CN101564425A Traditional Chinese medicine composition for curing allergic rhinitis
10/28/2009CN101564418A Pharmaceutical composition for treating oral ulcer and Behcet syndrome
10/28/2009CN101564417A Traditional Chinese medicine composition for preventing infectious rhinitis of fowl and preparation method thereof
10/28/2009CN101564407A Process for refining isatis root extract by applying membrane separation technique
10/28/2009CN101564406A Chinese medicinal composition for acute and chronic laryngopharyngitis
10/28/2009CN101564397A Difluprednate and tobramycin containing composition for eyes or ears and nose and application thereof
10/28/2009CN101564396A Two chamber type nose spraying agent for treating allergic rhinitis
10/28/2009CN101564395A Ophthalmic or otic and nasal composition containing difluprednate and lavo-ofloxacin and application thereof
10/28/2009CN101564165A Erdong bulbus fritilariae cream
10/28/2009CN100554267C Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
10/28/2009CN100553665C Chinese traditional medicine compound for treating faucitis
10/28/2009CN100553656C Mongol medicine for treating respiratory inflammation
10/28/2009CN100553636C Method of using diketopiperazines and composition containing them
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 878